The Pender Strategic Growth and Income Fund is a conservatively managed balanced fund. The fixed income strategy of the Fund will be primarily effected through the Pender Corporate Bond Fund, with weightings generally ranging from 30-60%, and may vary depending on market conditions. The remaining assets will be mainly in equities. Direct equity strategy will be primarily effected through small to mid-sized Canadian and US companies, with an emphasis on businesses that generate stable or growing cash distributions to shareholders. The Fund provides uncapped access to the Pender Small Cap Opportunities Fund, with weightings ranging from 5-10%.
Class | Fund Codes | Description | MER (Capped) | Minimum Investment: Initial/[Subsequent] |
A | PGF 600 | Front End | 2.25% | $5,000 / [$100] |
F | PGF 610 | Fee Based | 1.25% | $5,000 / [$100] |
H | PGF 640 | Front End – HNW | 1.95% | $100,000 / [$100] |
I | PGF 650 | Fee Based – HNW | 1.10% | $100,000 / [$100] |
D | PGF 660 | Discount Brokerage | 1.25% | $5,000 / [$100] |
Asset Class: Growth and Income Fund |
Inception Date: November 24, 2010 |
Valuation Frequency: Daily |
Eligibility: Canada-wide, Registered Plans |
Distributions: DRIP quarterly, cash optional |
Benchmark: Blended Benchmark (50% FTSE/TMX Canada Universe Bond Index, 35% S&P/TSX Composite Index, 15% S&P 500 Index) |
Portfolio Manager: Felix Narhi, CFA Co- Manager: Geoff Castle |
For More Visit: Legal & Financial
The Pender Corporate Bond Fund capped off the year with a strong December, gaining 2.6%[1]. Despite a rather tumultuous period early in the pandemic, the full year turned out fairly well, ending with a total return after all fees and costs of 7.0%1. Annualized performance for the five years ending Dec 31, 2020 was 9.9%1. Download pdf Gains in December were led by our position in FireEye Inc. convertible notes, which surged on renewed interest in security software firms following a high-profile hack on several US entities. Other strength came from a successful par plus accrued cash recovery on the completion of Aceto Corp.’s liquidation. Commodity-related positions, including Transocean secured notes, also contributed positively. Weakness in the portfolio was limited, due to the fairly buoyant environment. However, we did see some pressure in the credit of both Accelerate Diagnostics and Intercept Pharmaceuticals. In both cases we continue to view total…
Mr. Narhi is the Chief Investment Officer of Pender and the Portfolio Manager of the Pender US All Cap Equity Fund and the Pender Strategic Growth and Income Fund, and Co-Manager of the Pender Value Fund.
Mr. Castle is the Portfolio Manager of the Pender Corporate Bond Fund and the Pender Bond Universe Fund. He began his investing career in 2000 and has experience in both public mutual funds and proprietary investment fund management for ultra-high net worth individuals.
Join our online community and receive a monthly round up of new blog posts, commentaries, podcasts, media coverage and more.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.